283 related articles for article (PubMed ID: 15871083)
1. [TACE: therapy of the HCC before liver transplantation--experiences].
Herber S; Schneider J; Brecher B; Höhler T; Thelen M; Otto G; Pitton MB
Rofo; 2005 May; 177(5):681-90. PubMed ID: 15871083
[TBL] [Abstract][Full Text] [Related]
2. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.
Herber S; Biesterfeld S; Franz U; Schneider J; Thies J; Schuchmann M; Düber C; Pitton MB; Otto G
Cardiovasc Intervent Radiol; 2008; 31(4):768-77. PubMed ID: 18196335
[TBL] [Abstract][Full Text] [Related]
3. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
[TBL] [Abstract][Full Text] [Related]
4. [Single center experience over a 5-year period with sequential transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC)].
Herber SC; Otto G; Woerns M; Moench C; Kanzler S; Junginger T; Schneider J; Schuchmann M; Kummer I; Manzl N; Düber C; Pitton MB
Rofo; 2007 Mar; 179(3):289-99. PubMed ID: 17325996
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
[TBL] [Abstract][Full Text] [Related]
6. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.
Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R
Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580
[TBL] [Abstract][Full Text] [Related]
7. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.
Bargellini I; Vignali C; Cioni R; Petruzzi P; Cicorelli A; Campani D; De Simone P; Filipponi F; Bartolozzi C
Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465
[TBL] [Abstract][Full Text] [Related]
8. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.
Majno PE; Adam R; Bismuth H; Castaing D; Ariche A; Krissat J; Perrin H; Azoulay D
Ann Surg; 1997 Dec; 226(6):688-701; discussion 701-3. PubMed ID: 9409568
[TBL] [Abstract][Full Text] [Related]
9. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
[TBL] [Abstract][Full Text] [Related]
10. Transarterial Chemoembolization Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma.
Hołówko W; Wróblewski T; Wojtaszek M; Grąt M; Kobryń K; Ziarkiewicz-Wróblewska B; Krawczyk M
Ann Transplant; 2015 Dec; 20():764-8. PubMed ID: 26712800
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
[TBL] [Abstract][Full Text] [Related]
12. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
[TBL] [Abstract][Full Text] [Related]
13. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
[TBL] [Abstract][Full Text] [Related]
14. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.
Otto G; Herber S; Heise M; Lohse AW; Mönch C; Bittinger F; Hoppe-Lotichius M; Schuchmann M; Victor A; Pitton M
Liver Transpl; 2006 Aug; 12(8):1260-7. PubMed ID: 16826556
[TBL] [Abstract][Full Text] [Related]
15. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
[TBL] [Abstract][Full Text] [Related]
16. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
Kim JH; Kim PN; Won HJ; Shin YM
AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
[TBL] [Abstract][Full Text] [Related]
17. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization.
Kim DY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Shin SW; Choo SW; Do YS; Rhee JC
World J Gastroenterol; 2006 Nov; 12(43):6992-7. PubMed ID: 17109521
[TBL] [Abstract][Full Text] [Related]
18. [Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study].
Gattoni F; Cornalba G; Brambilla G; Dova S; Pompili G; Rampoldi A; Damiani G; Carnevali G; Uslenghi CM
Radiol Med; 1998 Apr; 95(4):362-8. PubMed ID: 9676217
[TBL] [Abstract][Full Text] [Related]
19. Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
Kim HD; Shim JH; Kim GA; Shin YM; Yu E; Lee SG; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
J Hepatol; 2015 May; 62(5):1076-84. PubMed ID: 25529626
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation versus supraselective transarterial chemoembolization in palliative patients with hepatocellular carcinoma exceeding the Milan Criteria - is it time for a more individual approach?
Heinzow HS; Brockmann JG; Köhler M; Wolters HH; Senninger N; Schmidt H; Meister T
Ann Transplant; 2013 Oct; 18():515-24. PubMed ID: 24081430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]